Ad
related to: Novavax
Search results
Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their...
Simply Wall St. via Yahoo Finance· 2 hours agoThe investors in Novavax, Inc.'s (NASDAQ:NVAX) will be rubbing their hands together with glee today,...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 20 hours agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 4 hours agoShares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday,...
3 Meme Stocks That Are Likely to Crater in 2024
InvestorPlace· 2 hours agoMeme stocks have the potential to completely change the portfolio health even with a limited exposure of 5% to 10%. At the same time, there are meme...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 23 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 1 day agoPositive Points Novavax Inc (NASDAQ:NVAX) announced a significant global co-development and co-commercialization agreement with Sanofi, expected to generate approximately ...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 19 hours agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Zacks Investment Ideas feature highlights: GameStop, AMC, Novavax, Reddit and Tesla
Zacks via Yahoo Finance· 4 hours agoFor Immediate Release Chicago, IL – May 14, 2024 – Today, Zacks Investment Ideas feature highlights...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 22 hours agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...